Page 18 - JCBP-1-2

Journal of Clinical and
Basic Psychosomatics Melatonin for dementia therapy

https://doi.org/10.1111/nyas.14436 17: 166–169.
70. Shen S, Liao Q, Wong YK, et al., 2022, The role of melatonin https://doi.org/10.1097/JGP.0b013e318187de18
in the treatment of Type 2 diabetes mellitus and Alzheimer’s 81. Savaskan E, Ayoub MA, Ravid R, et al., 2005, Reduced
disease. Int J Biol Sci, 18: 983–994.
hippocampal MT2 melatonin receptor expression in
https://doi.org/10.7150/ijbs.66871 Alzheimer’s disease. J Pineal Res, 38: 10–16.
71. Rosales-Corral SA, Lopez-Armas G, Cruz-Ramos J, et al., https://doi.org/10.1111/j.1600-079X.2004.00169.x
2012, Alterations in lipid levels of mitochondrial membranes
induced by Amyloid-β: A protective role of melatonin. Int J 82. Ono K, Mochizuki H, Ikeda T, et al., 2012, Effect of
Alzheimers Dis, 2012: 459806. melatonin on α-synuclein self-assembly and cytotoxicity.
Neurobiol Aging, 33: 2172–2185.
https://doi.org/10.1155/2012/459806
https://doi.org/10.1016/j.neurobiolaging.2011.10.015
72. O’Day DH, Eshak K, Myre MA, 2015, Calmodulin binding
proteins and Alzheimer’s disease. J Alzheimers Dis, 83. Chen ST, Chuang JI, Hong MH, et al., 2002, Melatonin
46: 553–569. attenuates MPP+-induced neurodegeneration and
glutathione impairment in the nigrostriatal dopaminergic
https://doi.org/10.3233/JAD-142772 pathway. J Pineal Res, 32: 262–269.
73. Reese LC, Taglialatela G, 2011, A role for calcineurin in https://doi.org/10.1034/j.1600-079x.2002.01871.x
Alzheimer’s disease. Curr Neuropharmacol, 9: 685–692.
84. Brito-Armas JM, Baekelandt V, Castro-Hernández JR, et al.,
https://doi.org/10.2174/157015911798376316 2013, Melatonin prevents dopaminergic cell loss induced by
74. Premratanachai A, Suwanjang W, Govitrapong P, lentiviral vectors expressing a30p mutant alpha-synuclein.
et al., 2020, Melatonin prevents calcineurin-activated the Histol Histopathol, 28: 999–1006.
nuclear translocation of nuclear factor of activated T-cells https://doi.org/10.14670/HH-28.999
in human neuroblastoma SH-SY5Y cells undergoing
hydrogen peroxide-induced cell death. J Chem Neuroanat, 85. Maurizi CP, 2000, A preliminary understanding of mania:
106: 101793. Roles for melatonin, vasotocin and rapid-eye-movement
sleep. Med Hypotheses, 54: 26–29.
https://doi.org/10.1016/j.jchemneu.2020.101793
https://doi.org/10.1054/mehy.1998.0812
75. Penny CJ, Gold MG, 2018, Mechanisms for localising
calcineurin and CaMKII in dendritic spines. Cell Signal, 86. Thangwong P, Jearjaroen P, Tocharus C, et al., 2023,
49: 46–58. Melatonin suppresses inflammation and blood-brain
barrier disruption in rats with vascular dementia possibly
https://doi.org/10.1016/j.cellsig.2018.05.010 by activating the SIRT1/PGC-1α/pparγ signaling pathway.
76. Kubokawa M, Nakamura K, Komagiri Y, 2011, Interaction Inflammopharmacology, 31: 1481–1493.
between calcineurin and Ca/calmodulin kinase-II in https://doi.org/10.1007/s10787-023-01181-5
modulating cellular functions. Enzyme Res, 2011: 587359.
87. Singh P, Gupta S, Sharma B, 2015, Melatonin receptor
https://doi.org/10.4061/2011/587359 and K ATP channel modulation in experimental vascular
77. Fukunaga K, Izumi H, Yabuki Y, et al., 2019, Alzheimer’s dementia. Physiol Behav, 142: 66–78.
disease therapeutic candidate SAK3 is an enhancer of T-type https://doi.org/10.1016/j.physbeh.2015.02.009
calcium channels. J Pharmacol Sci, 139: 51–58.
88. Thangwong P, Jearjaroen P, Govitrapong P, et al., 2022,
https://doi.org/10.1016/j.jphs.2018.11.014 Melatonin improves cognitive function by suppressing
78. Meeks TW, Ropacki SA, Jeste DV, 2006, The neurobiology endoplasmic reticulum stress and promoting synaptic
of neuropsychiatric syndromes in dementia. Curr Opin plasticity during chronic cerebral hypoperfusion in rats.
Psychiatry, 19: 581–586. Biochem Pharmacol, 198: 114980.
https://doi.org/10.1097/01.yco.0000245746.45384.0e https://doi.org/10.1016/j.bcp.2022.114980
79. Srinivasan V, Kaur C, Pandi-Perumal S, et al., 2010, Melatonin 89. Gupta S, Singh P, Sharma BM, et al., 2015, Neuroprotective
and its agonist ramelteon in Alzheimer’s disease: Possible effects of agomelatine and vinpocetine against chronic
therapeutic value. Int J Alzheimers Dis, 2011: 741974. cerebral hypoperfusion induced vascular dementia. Curr
neurovasc Res, 12: 240–252.
https://doi.org/10.4061/2011/741974
https://doi.org/10.2174/1567202612666150603130235
80. Gehrman PR, Connor DJ, Martin JL, et al., 2009, Melatonin
fails to improve sleep or agitation in double-blind 90. Bin-Jaliah I, Sakr HF, 2018, Melatonin ameliorates brain
randomized placebo-controlled trial of institutionalized oxidative stress and upregulates senescence marker
patients with Alzheimer disease. Am J Geriatr Psychiatry, protein-30 and osteopontin in a rat model of vascular

Volume 1 Issue 2 (2023) 12 https://doi.org/10.36922/jcbp.1174